Platelet monoamine oxidase-A activity and aging: Effect of carnosine

Journal of Physiological Sciences

Volumn 63, Issue 4, 2013, Pages 279-285

  Banerjee, S ^a   Poddar, M K ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Aging; Blood platelet; Carnosine; Monoamine oxidase A (MAO A)

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CARNOSINE; SEROTONIN;

AGING; ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; ENZYMOLOGY; KINETICS; MALE; RAT; THROMBOCYTE; WISTAR RAT;

AGING; ANIMALS; BLOOD PLATELETS; CARNOSINE; KINETICS; MALE; MONOAMINE OXIDASE; RATS; RATS, WISTAR; SEROTONIN;

EID: 84879941928     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-013-0264-9     Document Type: Article

References (53)

1. Tipton KF, Boyce S, O' Sullivan J, Davey GP, Healy J (2004) Monoamine oxidases: certainties and uncertainties. Curr Med Chem 11:1965-1982
2. Benedetti MS, Keane PE (1980) Differential changes in monoamine oxidase A and B activity in the aging rat brain. J Neurochem 35:1026-1032
3. Edmondson DE, Mattevi A, Binda C, Li M, Hubalck F (2004) Structure and mechanism of monoamine oxidase. Curr Med Chem 11:1983-1993
4. Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285-1297
5. Del VM, Maj M, D'Ambrosio A, Kemali D (1983) Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment? Psychopharmacology 79:177-179
6. Baron M, Levitt M, Perlman R (1980) Low platelet monoamine oxidase activity: a possible biochemical correlate of borderline schizophrenia. Psychiatry Res 3:329-335
7. Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27:1029-1034
8. Alexopoulos GS, Liberman KW, Yang RC (1984) Platelet MAO activity in primary degenerative dementia. Am J Psychiatry 141:97-99
9. Bongioanni P, Mondino C, Boccardi B, Borgna M, Castagna M (1996) Monoamine oxidase molecular activity in platelets of Parkinsonian and demented patients. Neurodegeneration 5:351-357
10. Parnetti L, Reboldi GP, Santucci C, Santucci A, Gaiti A, Brunetti M, Cecchetti R, Senin U (1994) Platelet MAO-B activity as a marker of behavioral characteristics in dementia disorders. Aging Milano 6:201-207
11. Holiday R, McFarland GA (2000) A role for carnosine in cellular maintenance. Biochemistry (Mosc) 65:843-848
12. Kohen R, Yammamoto Y, Cundy KC, Ames BN (1988) Antioxidant activity of carnosine, homocarnosine and anserine present in muscle and brain. Proc Natl Acad Sci USA 85:3175-3179
13. Seely JE, Marshall FD (1981) Carnosine levels in blood. In. Experientia 37:1256-1257 (Publisher Birkhauser Verlag)
14. Wim D, Inge E, Sam B, Audrey B (2010) Muscle carnosine metabolism and β-alanine supplementation in relation to exercise and training. Sports Med 40:247-263
15. Ng RH, Marshall FD (1976) Subcellular distribution and some properties of homocarnosine-carnosine synthetase from chick red blood cells. Comp Biochem Physiol B 54:523-525
16. Lunde HA, Lenney JF, Halvorsen S, Gjessing L (1987) Serum carnosine in blood and homocarnosine in CSF of patients with Folling's disease (PKU). J Oslo City Hosp 37:29-33
17. Jackson MC, Kucera CM, Lenney JF (1991) Purification and properties of human serum carnosinase. Clin Chim Acta 196:193-205
18. Peppers SC, Lenney JF (1988) Bestatin inhibition of human tissue carnosinase, a non-specific cytosolic dipeptidase. Biol Chem Hoppe Seyler 369:1281-1286
19. Margles FL (1994) Carnosine in the primary olfactory pathway. Science 184:909-911
20. Bellia F, Calabrese V, Guarino F, Cavallaro M, Cornelius C, De Pinto V, Rizzarelli E (2009) Carnosinase levels in aging brain: redox state induction and cellular stress response. Antioxid Redox Signal 11:2759-2775
21. Boldyrev AA, Kurella EG, Stovoliusky SL (1994) Biological role of carnosine metabolism in excitable tissues: speculations and facts (a commentary). Pathophysiology 1:215-219
22. Quinn PJ, Boldyrev AA, Formazuyk VE (1992) Carnosine, its properties, functions and potential therapeutic applications. Mol Asp Med 13:379-444
23. Neurhro KJ, Mantiesh HH (1979) Complete formation of carnosine with purine nucleotides in aqueous solution. Z Naturforsch C 35:557-561
24. Mc Farland GA, Holiday R (1994) Retardation of senescence of cultured human fibroblasts carnosine. Exp Cell Res 212:167-175
25. Stuerenburg HJ, Kunze K (1999) Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle biopsies and rat muscle. Arch Gerentol Geriatr 29:107-113
26. Boldyrev A, Song R, Lowrence D, Carpenter DO (1999) Carnosine protects against excitotoxicity cell death independently of effects on reactive oxygen species. Neuroscience 94:571-577
27. Meszaros Z, Borcsiozky D, Mate M, Tarcali J, Szombathy T, Mekes K, Magyar K (1998) Platelet MAO-B activity and serotonin content in patients with dementia: effect of age, medication and disease. Neurochem Res 23:863-868
28. Yang M, Srikiatkhachorn A, Anthony M, Chong BH (1996) Serotonin stimulates megakaryocytopoesis via the 5HT-2 receptor. Blood Coagul Fibrinolysis 7:127-133
29. Lopez-Vilchez I, Diaz-Ricart M, White JG, Escolar G, Galan AM (2009) Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Cardiovascular Res 84:309-316
30. Collins GGS, Sandler M (1971) Human blood platelet MAO. Biochem Pharmacol 20:289-297
31. 9- tetrahydrocannabinol on membrane-bound monoamine oxidase activity. Toxicol Appl Pharmacol 40:347-354
32. Dalal A, Poddar MK (2010) Involvement of high plasma corticosteron status and activation of brain regional serotonin metabolism in long-term erythrosine induced rearing motor hyperactivity in young adult male rats. Toxicol Mech Methods 20:287-297
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin-phenol reagent. J Biol Chem 193:265-275
34. Saura J, Richards JG, Mahy N (1994) Age-related changes on MAO in B1/C57 mouse tissues: a quantitative radiographic study. J Neural Transm Suppl 41:89-94
35. Holschneider DP, Shih JC (2000) Monoamine oxidase: basic and clinical perspectives. Neuropsychopharmacology: the fifth generation of progress. http://www.acnp.org/g4/gn401000046/ch046.html
36. Jon V, Keith DC, Richard C, Marwan NS, Geoffrey LA, Leslie B, Gene A, Douglas GW, Eric MR (2006) Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6:323-330
37. Chun S, Kaihua G, David TY, Zhibin Y, Lucy Forster E, Huaqiao W, Jie Xu (2008) Effects of aging and Alzheimer's disease on mitochondrial function of human platelets. Exp Gerentol 43:589-594
38. Lenaz G, D'Aurelio M, Merlo Pich M, Genova ML, Ventura C, Bovina C, Formiggini G, Parenti Castelli G (2000) Mitochondrial bioenergetics in aging. Biochem Biophys Acta 1459:397-404
39. Parker WD Jr, Mahr NJ, Filley CM, Parks JK, Hughes D, Young DA, Cullum CA (1994) Reduced platelet cytochrome oxidase activity in Alzheimer's disease. Neurology 44:1086-1090
40. Aurelio Marilena D', Milena MP, Lucia C, Gian LS, Carla B, Gabriella F, Giovanna PC, Harold B, Sante T, Giorgio L (2001) Decreased Pasteur effect in platelets of aged individuals. Mech Ageing Dev 122:823-833
41. Jie X, Shi C, Li Q, Lam WP, Wai MSM, Yew DT (2007) Effects of β-amyloid peptide and estrogen on platelet mitochondrial function of Sprague-Dawley rats. Platelets 18:460-468
42. Fumagalli F, Jones SR, Caron MG, Seidler FJ, Slotkin TA (1996) Expression of mRNA coding for the serotonin transporter in aged vs. young rat brain: differential effects of glucocorticoids. Brain Res 719:225-228
43. Xm Ou, Chen K, Shih JC (2006) Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and SP1. J Biol Chem 281:21512-21525
44. Maurel A, Hernandez C, Kunduzova O, Bompart G, Cambon C, Parini A, Frances B (2003) Age dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am J Physiol Heart Circ Physiol 284:H1460-H1467
45. Kabuto H, Yokoi I, Mori A, Murakami M, Sawada S (1995) Neurochemical changes related to ageing in the senescence-accelerated mouse brain and the effects of chronic administration of nimodipine. Mech Ageing Dev 80:1-9
46. Zeirmans T, Dumontheil I, Roggeman C, Peyrard-Janvid M, Matsson H, Kere J, Klingberg T (2012) Working memory, brain activity and capacity link MAO-A polymorphism to aggressive behavior during development. Transl Psychi 2:E85. doi: 10.1038/TP.2012.7
47. Nunes SF, Figueiredo IV, Pereira JS, De Lemos ET, Reis F, Teixeira F, Caramona MM (2011) Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes. Physiol Res 60:309-315
48. Herriz T, Chaparro C (2006) Analysis of monoamine oxidase enzymatic activity by reversed phase high performance liquid chromatography and inhibition by beta-carboline alkaloids occurring in foods and plants. J Chromatogr A 1120:237-243
49. Zhang X, Yuan CL, Zhang HZ, Huang RX (2003) Age-related increase of plasma platelet-activating factor concentrations in Chinese. Clin Chim Acta 337:157-162
50. Hidetaka I, Yoshimi T, Kozo K, Makoto S, Yasutomi N (1982) A role of calcium-activated, phospholipid-dependent protein kinase in platelet-activating factor-induced serotonin release from rabbit platelets. Biochem Biophys Res Commun 108:1701-1708
51. Moore S (1976) Platelet aggregation secondary to coronary obstruction. Circulation 53:166-169
52. Gerhard M (1974) Determination of Michaelis constants and inhibitor constants. In: Bergmeyer HU (ed) Methods of enzymatic analysis, vol 1, 2nd English edn. Academic Press Inc, New York-San Francisco-London, pp 146-151
53. Masciandaro GBC, Rouchi V (2000) Kinetic parameters of dehydrogenase in the assessment of the response of soil to vermicompost and inorganic fertilizers. Biol Fert Soils 32:479-483